Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19
Date
2022
Type:
Article
item.page.extent
item.page.accessRights
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.other
item.page.references
Abstract
Pediatric Coronavirus Disease 2019 (pCOVID-19) is rarely severe; however, a minority of children infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) might develop multisystem inflammatory syndrome in children (MIS-C),
with substantial morbidity. In this longitudinal multi-institutional study, we applied multi-omics (analysis of soluble biomarkers,
proteomics, single-cell gene expression and immune repertoire analysis) to profile children with COVID-19 (n= 110) and MIS-C
(n= 76), along with pediatric healthy controls (pHCs; n= 76). pCOVID-19 was characterized by robust type I interferon (IFN)
responses, whereas prominent type II IFN-dependent and NF-κB-dependent signatures, matrisome activation and increased
levels of circulating spike protein were detected in MIS-C, with no correlation with SARS-CoV-2 PCR status around the time
of admission. Transient expansion of TRBV11-2 T cell clonotypes in MIS-C was associated with signatures of inflammation and
T cell activation. The association of MIS-C with the combination of HLA A*02, B*35 and C*04 alleles suggests genetic susceptibility. MIS-C B cells showed higher mutation load than pCOVID-19 and pHC. These results identify distinct immunopathological
signatures in pCOVID-19 and MIS-C that might help better define the pathophysiology of these disorders and guide therapy
Description
Francesco Licciardi; Ugo Ramenghi; Valentina Discepolo; Andrea Lo Vecchio; Alfredo Guarino; Eli M. Eisenstein; Luisa Imberti ; Alessandra Sottini; Andrea Biondi; Sayonara Mató; Dana Gerstbacher; Meng Truong; Michael A. Stack; Mary Magliocco; Marita Bosticardo; Tomoki Kawai; Jeffrey J. Danielson; Tyler Hulett; Manor Askenazi; Shaohui Hu; NIAID Immune Response to COVID Group*; Chile MIS-C Group*; Pavia Pediatric; COVID-19 Group*; Jeffrey I. Cohen; Helen C. Su ; Douglas B. Kuhns; Michail S. Lionakis
Thomas M. Snyder; Steven M. Holland; Raphaela Goldbach-Mansky; John S. Tsang and Luigi D. Notarangelo
item.page.coverage.spatial
item.page.sponsorship
Citation
Sacco, K., Castagnoli, R., Vakkilainen, S. et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med (2022). https://doi.org/10.1038/s41591-022-01724-3
Keywords
Immunopathogenesis, Inflammation, RNA sequencing, SARS-CoV-2, Viral infection